Cargando…

FGFR2-Driven Signaling Counteracts Tamoxifen Effect on ERα-Positive Breast Cancer Cells

Signaling mediated by growth factors receptors has long been suggested as one of the key factors responsible for failure of endocrine treatment in breast cancer (BCa). Herein we present that in the presence of tamoxifen, FGFs (Fibroblast Growth Factors) promote BCa cell growth with the strongest eff...

Descripción completa

Detalles Bibliográficos
Autores principales:	Turczyk, Lukasz, Kitowska, Kamila, Mieszkowska, Magdalena, Mieczkowski, Kamil, Czaplinska, Dominika, Piasecka, Dominika, Kordek, Radzisław, Skladanowski, Andrzej C., Potemski, Piotr, Romanska, Hanna M., Sadej, Rafal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2017
Materias:	Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5964976/ https://www.ncbi.nlm.nih.gov/pubmed/28869838 http://dx.doi.org/10.1016/j.neo.2017.07.006

Ejemplares similares

Fibroblast growth factor signalling induces loss of progesterone receptor in breast cancer cells
por: Piasecka, Dominika, et al.
Publicado: (2016)

FGFs/FGFRs-dependent signalling in regulation of steroid hormone receptors – implications for therapy of luminal breast cancer
por: Piasecka, Dominika, et al.
Publicado: (2019)

FGF7/FGFR2–JunB signalling counteracts the effect of progesterone in luminal breast cancer
por: Mieczkowski, Kamil, et al.
Publicado: (2022)

Interactions between FGFR2 and RSK2—implications for breast cancer prognosis
por: Czaplinska, Dominika, et al.
Publicado: (2016)

A ‘Real-Life’ Experience on Automated Digital Image Analysis of FGFR2 Immunohistochemistry in Breast Cancer
por: Braun, Marcin, et al.
Publicado: (2020)

Hormonal Receptor Status Determines Prognostic Significance of FGFR2 in Invasive Breast Carcinoma
por: Braun, Marcin, et al.
Publicado: (2020)

Upregulation of HIF1-α via an NF-κB/COX2 pathway confers proliferative dominance of HER2-negative ductal carcinoma in situ cells in response to inflammatory stimuli
por: Piasecka, Dominika, et al.
Publicado: (2020)

MicroRNAs in regulation of triple-negative breast cancer progression
por: Piasecka, Dominika, et al.
Publicado: (2018)

MET-Pyk2 Axis Mediates Acquired Resistance to FGFR Inhibition in Cancer Cells
por: Kitowska, Kamila, et al.
Publicado: (2021)

FGFR2 Controls Growth, Adhesion and Migration of Nontumorigenic Human Mammary Epithelial Cells by Regulation of Integrin β1 Degradation
por: Mieczkowski, Kamil, et al.
Publicado: (2023)

Lack of CD151/integrin α3β1 complex is predictive of poor outcome in node-negative lobular breast carcinoma: opposing roles of CD151 in invasive lobular and ductal breast cancers
por: Romanska, Hanna M, et al.
Publicado: (2015)

Profiling of Invasive Breast Carcinoma Circulating Tumour Cells—Are We Ready for the ‘Liquid’ Revolution?
por: Braun, Marcin, et al.
Publicado: (2019)

p38 Mediates Resistance to FGFR Inhibition in Non-Small Cell Lung Cancer
por: Zarczynska, Izabela, et al.
Publicado: (2021)

Ossifying fasciitis at an extraordinary site – a case report and analysis of diagnostic pitfalls
por: Kowalczyk, Łukasz, et al.
Publicado: (2019)

Subtype-Specific Tumour Immune Microenvironment in Risk of Recurrence of Ductal Carcinoma In Situ: Prognostic Value of HER2
por: Solek, Julia, et al.
Publicado: (2022)

Basal keratin expression in breast cancer by quantification of mRNA and by immunohistochemistry
por: Kordek, Radzislaw, et al.
Publicado: (2010)

FGFR1 Is Associated With Tamoxifen Resistance and Poor Prognosis of ER-Positive Breast Cancers by Suppressing ER Protein Expression
por: Lv, Qing, et al.
Publicado: (2021)

Analysis of cancer tissues by means of spectroscopic methods
por: Pacholczyk, Barbara, et al.
Publicado: (2012)

The diagnostic challenge in pulmonary tumour embolism in cancer: a case report and literature review
por: Zielińska, Aleksandra, et al.
Publicado: (2021)

Influence of genomic variation in FTO at 16q12.2, MC4R at 18q22 and NRXN3 at 14q31 genes on breast cancer risk
por: Kusinska, Renata, et al.
Publicado: (2011)

Tamoxifen-induced acute pancreatitis – a case report
por: Czyżykowski, Rafał, et al.
Publicado: (2014)

WWOX expression in colorectal cancer—a real-time quantitative RT-PCR study
por: Żelazowski, Maciej Jakub, et al.
Publicado: (2011)

Does vimentin help to delineate the so-called 'basal type breast cancer'?
por: Kusinska, Renata U, et al.
Publicado: (2009)

Molecular analysis of WWOX expression correlation with proliferation and apoptosis in glioblastoma multiforme
por: Kosla, Katarzyna, et al.
Publicado: (2010)

FGF/FGFR-Dependent Molecular Mechanisms Underlying Anti-Cancer Drug Resistance
por: Szymczyk, Jakub, et al.
Publicado: (2021)

Intertumoral Heterogeneity of Primary Breast Tumors and Synchronous Axillary Lymph Node Metastases Reflected in IHC-Assessed Expression of Routine and Nonstandard Biomarkers
por: Kuncman, Wojciech, et al.
Publicado: (2021)

Tamoxifen Action in ER-Negative Breast Cancer
por: Manna, Subrata, et al.
Publicado: (2016)

Assessment of the TGFB1 gene expression and methylation status of the promoter region in patients with colorectal cancer
por: Wodziński, Damian, et al.
Publicado: (2022)

Receptor clustering by a precise set of extracellular galectins initiates FGFR signaling
por: Zukowska, Dominika, et al.
Publicado: (2023)

Tamoxifen-Independent Recombination in the RIP-CreER Mouse
por: Liu, Yanmei, et al.
Publicado: (2010)

Tamoxifen may prevent both ER+ and ER- breast cancers and select for ER- carcinogenesis: an alternative hypothesis
por: Esserman, Laura J, et al.
Publicado: (2005)

MiR-21, miR-34a, miR-125b, miR-181d and miR-648 levels inversely correlate with MGMT and TP53 expression in primary glioblastoma patients
por: Jesionek-Kupnicka, Dorota, et al.
Publicado: (2017)

N-glycosylation acts as a switch for FGFR1 trafficking between the plasma membrane and nuclear envelope
por: Gregorczyk, Paulina, et al.
Publicado: (2023)

cDNA sequencing improves the detection of P53 missense mutations in colorectal cancer
por: Szybka, Malgorzata, et al.
Publicado: (2009)

Raman imaging at biological interfaces: applications in breast cancer diagnosis
por: Surmacki, Jakub, et al.
Publicado: (2013)

Stratification of Tamoxifen Synergistic Combinations for the Treatment of ER+ Breast Cancer
por: Zboril, Emily K., et al.
Publicado: (2023)

Primary small-cell carcinoma of the palate – the second case report worldwide
por: Kozak-Rusinek, Agnieszka, et al.
Publicado: (2016)

Analysis of Human Colon by Raman Spectroscopy and Imaging-Elucidation of Biochemical Changes in Carcinogenesis
por: Brozek-Pluska, Beata, et al.
Publicado: (2019)

Label-free diagnostics and cancer surgery Raman spectra guidance for the human colon at different excitation wavelengths
por: Brozek-Pluska, Beata, et al.
Publicado: (2019)

A malignant astrocytoma with uncommon angiocentric features and dot-like EMA expression
por: Kuncman, Wojciech, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_n0mlad5cekl603i7pd7r1tbg7t